- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Prosensa Holding NV+ Add to Watchlist
RNA:US9.4800 USD 0.2400 2.60%
As of 16:30:00 ET on 07/23/2014.
Company Profile for Prosensa Holding NV (RNA)
Prosensa Holding NV is a biotechnology company engaged in the discovery and development of ribonucleic acid-modulating, or RNA-modulating, therapeutics for the treatment of genetic disorders. The Company's primary focus is on neuromuscular and neurodegenerative disorders, including Duchenne muscular dystrophy, myotonic dystrophy and Huntington's disease.
Prosensa Holding NV
Key Executives for Prosensa Holding NV (RNA)
|Hans G C P SchikanCEO/Member-Mgmt Board||Berndt A E ModigCFO/Member-Mgmt Board|
|Willem W Van WeperenChief Commercial Officer||Giles CampionSenior VP:Research & Dev|
|Luc DochezSenior VP:Bus Dev/Chief Bus Ofcr|